Carter Bankshares, Inc. (CARE) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CARE Revenue Growth
Revenue Breakdown (FY 2025)
CARE's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
CARE Revenue Analysis (2014–2025)
As of May 7, 2026, Carter Bankshares, Inc. (CARE) generated trailing twelve-month (TTM) revenue of $251.7 million, reflecting solid growth of +5.9% year-over-year. The most recent quarter (Q4 2025) recorded $64.5 million in revenue, up 1.5% sequentially.
Looking at the longer-term picture, CARE's 5-year compound annual growth rate (CAGR) stands at +9.2%, indicating steady revenue expansion. The company achieved its highest annual revenue of $254.6 million in 2025, representing a new all-time high.
Revenue diversification analysis shows CARE's business is primarily driven by Bank Owned Life Insurance Income (74%), and Other Revenue (26%). With over half of revenue concentrated in Bank Owned Life Insurance Income, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including NBTB, UVSP, and NFBK. Compare CARE vs NBTB →
CARE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CARECurrent | $252M | +5.9% | +9.2% | 15.7% | |
 NBTB | $867M | - | - | 25.3% | |
 UVSP | $518M | - | - | 21.9% | |
 NFBK | $251M | - | - | 16.1% | |
 MNSB | $136M | - | - | 14.0% | |
 NKSH | $85M | - | - | 22.5% |
CARE Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $254.6M | - | $157.1M | 61.7% | $40.0M | 15.7% |
| 2024 | $239.7M | - | $137.4M | 57.3% | $30.9M | 12.9% |
| 2023 | $211.8M | - | $131.3M | 62.0% | $28.7M | 13.6% |
| 2022 | $179.2M | - | $156.0M | 87.1% | $61.7M | 34.4% |
| 2021 | $156.4M | - | $131.6M | 84.1% | $35.7M | 22.8% |
| 2020 | $163.8M | - | $109.9M | 67.1% | $-45,086,000 | -27.5% |
| 2019 | $168.4M | - | $118.2M | 70.2% | $27.8M | 16.5% |
| 2018 | $157.9M | - | $102.9M | 65.2% | $14.3M | 9.1% |
| 2017 | $144.3M | - | $64.0M | 44.4% | $-18,212,000 | -12.6% |
| 2016 | $146.7M | - | $82.6M | 56.3% | $17.6M | 12.0% |
See CARE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CARE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CARE vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonCARE — Frequently Asked Questions
Quick answers to the most common questions about buying CARE stock.
Is CARE's revenue growth accelerating or slowing?
CARE maintains +5.9% revenue growth, in line with its 5-year CAGR of +9.2%. TTM revenue stands at $252M. Growth rate remains consistent with historical average.
What is CARE's long-term revenue growth rate?
Carter Bankshares, Inc.'s 5-year revenue CAGR of +9.2% reflects the sustained expansion pattern. Current YoY growth of +5.9% is near this long-term average.
How is CARE's revenue distributed by segment?
CARE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.